Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | RPRX |
---|---|---|
09:32 ET | 24133 | 25.97 |
09:34 ET | 12622 | 26.07 |
09:36 ET | 3215 | 26.03 |
09:38 ET | 3257 | 26.105 |
09:39 ET | 3510 | 26.09 |
09:41 ET | 9672 | 26.16 |
09:43 ET | 7966 | 26.22 |
09:45 ET | 11567 | 26.23 |
09:48 ET | 7287 | 26.205 |
09:50 ET | 8690 | 26.28 |
09:52 ET | 5978 | 26.27 |
09:54 ET | 8687 | 26.25 |
09:56 ET | 9171 | 26.26 |
09:57 ET | 4272 | 26.3 |
09:59 ET | 4078 | 26.28 |
10:01 ET | 27510 | 26.335 |
10:03 ET | 6320 | 26.28 |
10:06 ET | 5301 | 26.29 |
10:08 ET | 10810 | 26.295 |
10:10 ET | 5131 | 26.285 |
10:12 ET | 9863 | 26.255 |
10:14 ET | 11848 | 26.275 |
10:15 ET | 7642 | 26.29 |
10:17 ET | 59153 | 26.26 |
10:19 ET | 43666 | 26.185 |
10:21 ET | 4674 | 26.17 |
10:24 ET | 5125 | 26.19 |
10:26 ET | 10854 | 26.25 |
10:28 ET | 4870 | 26.17 |
10:30 ET | 1635 | 26.17 |
10:32 ET | 7647 | 26.14 |
10:33 ET | 2600 | 26.095 |
10:35 ET | 3720 | 26.09 |
10:37 ET | 4739 | 26.065 |
10:39 ET | 5258 | 26.035 |
10:42 ET | 5059 | 26.045 |
10:44 ET | 17145 | 26.045 |
10:46 ET | 8267 | 26.05 |
10:48 ET | 9605 | 26.07 |
10:50 ET | 7442 | 26.075 |
10:51 ET | 4544 | 26.08 |
10:53 ET | 11027 | 26.045 |
10:55 ET | 4313 | 26.035 |
10:57 ET | 6960 | 26.015 |
11:00 ET | 11217 | 26.03 |
11:02 ET | 17051 | 25.975 |
11:04 ET | 8863 | 26.025 |
11:06 ET | 1500 | 26.035 |
11:08 ET | 10477 | 26.015 |
11:09 ET | 6128 | 26.02 |
11:11 ET | 47220 | 25.98 |
11:13 ET | 20155 | 25.965 |
11:15 ET | 7153 | 25.995 |
11:18 ET | 12616 | 25.96 |
11:20 ET | 4251 | 25.99 |
11:22 ET | 3575 | 25.97 |
11:24 ET | 6960 | 26.015 |
11:26 ET | 2161 | 26 |
11:27 ET | 3000 | 25.97 |
11:29 ET | 26814 | 25.95 |
11:31 ET | 5574 | 25.91 |
11:33 ET | 4346 | 25.914 |
11:36 ET | 5234 | 25.935 |
11:38 ET | 4140 | 25.935 |
11:40 ET | 4097 | 25.97 |
11:42 ET | 2050 | 25.97 |
11:44 ET | 4948 | 26 |
11:45 ET | 9761 | 25.935 |
11:47 ET | 3373 | 25.95 |
11:49 ET | 13080 | 25.94 |
11:51 ET | 1490 | 25.935 |
11:54 ET | 4986 | 25.96 |
11:56 ET | 6052 | 25.975 |
11:58 ET | 1992 | 25.9699 |
12:00 ET | 2755 | 25.955 |
12:02 ET | 6244 | 25.94 |
12:03 ET | 1035 | 25.935 |
12:05 ET | 5138 | 25.955 |
12:07 ET | 5097 | 25.94 |
12:09 ET | 1158 | 25.94 |
12:12 ET | 6252 | 25.935 |
12:14 ET | 5065 | 25.955 |
12:16 ET | 5322 | 25.9694 |
12:18 ET | 4223 | 25.96 |
12:20 ET | 1860 | 25.955 |
12:21 ET | 8212 | 25.97 |
12:23 ET | 5265 | 25.96 |
12:25 ET | 400 | 25.955 |
12:27 ET | 5732 | 25.91 |
12:30 ET | 5393 | 25.915 |
12:32 ET | 7299 | 25.905 |
12:34 ET | 4283 | 25.87 |
12:36 ET | 8878 | 25.89 |
12:38 ET | 3940 | 25.89 |
12:39 ET | 10595 | 25.9 |
12:41 ET | 11905 | 25.92 |
12:43 ET | 11011 | 25.9336 |
12:45 ET | 6844 | 25.925 |
12:48 ET | 7945 | 25.935 |
12:50 ET | 6027 | 25.925 |
12:52 ET | 16518 | 25.95 |
12:54 ET | 14866 | 25.985 |
12:56 ET | 15150 | 26.005 |
12:57 ET | 16642 | 25.985 |
12:59 ET | 67447 | 25.92 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Royalty Pharma PLC | 15.5B | 14.5x | +1.83% |
Amneal Pharmaceuticals Inc | 2.0B | -12.0x | --- |
Catalent Inc | 10.2B | -8.7x | --- |
Jazz Pharmaceuticals PLC | 6.6B | 21.4x | -3.53% |
Mallinckrodt PLC | 1.6M | 0.0x | --- |
Prestige Consumer Healthcare Inc | 3.4B | 16.1x | --- |
Royalty Pharma plc is a buyer of biopharmaceutical royalties and a funder of innovation across the biopharmaceutical industry. The Company collaborates with innovators from academic institutions, research hospitals and non-profits through small and mid-cap biotechnology companies to global pharmaceutical companies. Its portfolio consists of royalties on over 35 commercial products, including Vertex’s Trikafta, GSK’s Trelegy, Roche’s Evrysdi, Johnson & Johnson’s Tremfya, Biogen’s Tysabri and Spinraza, AbbVie and Johnson & Johnson’s Imbruvica, Astellas and Pfizer’s Xtandi, Novartis’ Promacta, Pfizer’s Nurtec ODT and Gilead’s Trodelvy, and 14 development-stage product candidates. Its development-stage product candidates include Aficamten, Ampreloxetine, BCX10013, MK-8189, Ecopipam, Olpasiran, Pelabresib, KarXT, Pelacarsen, Seltorexant, Trontinemab, TEV-'749, Tulmimetostat and Vanzacaftor. Its subsidiaries include Royalty Pharma Holdings Ltd., Royalty Pharma Investments and others.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $15.5B |
---|---|
Revenue (TTM) | $2.2B |
Shares Outstanding | 597.4M |
Dividend Yield | 3.24% |
Annual Dividend Rate | 0.8400 USD |
Ex-Dividend Date | 05-16-24 |
Pay Date | 06-14-24 |
Beta | 0.46 |
EPS | $1.78 |
Book Value | $14.61 |
P/E Ratio | 14.5x |
Price/Sales (TTM) | 6.9 |
Price/Cash Flow (TTM) | 13.0x |
Operating Margin | 41.96% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.